Source: centralcharts

Press Release: Dermira : Journey Medical Corporation Enters into a Definitive Agreement with Dermira, Inc., a Wholly-Owned Subsidiary of Eli Lilly and Company, to Acquire QBREXZA

SCOTTSDALE, Ariz. and NEW YORK, April 01, 2021 (GLOBE NEWSWIRE) -- Journey Medical Corporation ("Journey Medical"), a partner company of Fortress Biotech,

Read full article »
Est. Annual Revenue
$25-100M
Est. Employees
250-500
Andrew Hotchkiss's photo - CEO of Dermira

CEO

Andrew Hotchkiss

CEO Approval Rating

81/100

Read more